Key Points
- CEO Amit Gupta sold 7,382 Cardlytics shares at an average price of $2.53, reducing his stake by 5.05% and retaining 138,906 shares. He has also made several other sales in recent months.
- Cardlytics shares opened at $2.53, near their 52-week low of $2.47, with a market capitalization of approximately $14.69 million. The company remains unprofitable, reporting a quarterly loss of $1.50 per share and a negative net margin of 55.92%.
- Analyst sentiment is negative: two firms rate the stock “Sell” and one rates it “Hold,” producing a consensus “Sell” rating. Meanwhile, Worldly Partners Management acquired about 115,798 shares, and institutional investors own 68.1% of the company.
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Amit Gupta sold 7,382 shares of the business's stock in a transaction on Friday, October 2nd. The stock was sold at an average price of $2.53, for a total transaction of $18,676.46. Following the transaction, the chief executive officer owned 138,906 shares of the company's stock, valued at approximately $351,432.18. The trade was a 5.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
Amit Gupta also recently made the following trade(s):
- On Thursday, October 1st, Amit Gupta sold 10,351 shares of Cardlytics stock. The shares were sold at an average price of $2.71, for a total value of $28,051.21.
- On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The stock was sold at an average price of $4.03, for a total value of $26,904.28.
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The stock was sold at an average price of $3.97, for a total value of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total value of $42,319.60.
Cardlytics Stock Performance
Shares of NASDAQ CDLX opened at $2.53 on Friday. The stock's 50-day simple moving average is $3.81 and its 200-day simple moving average is $5.87. The firm has a market capitalization of $14.69 million, a PE ratio of -0.14 and a beta of 0.71. Cardlytics, Inc. has a fifty-two week low of $2.47 and a fifty-two week high of $26.70.
Cardlytics (NASDAQ:CDLX - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($1.50) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.30) by $0.80. The firm had revenue of $36.88 million during the quarter, compared to the consensus estimate of $37.00 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 55.92%. On average, sell-side analysts forecast that Cardlytics, Inc. will post -3.89 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Cardlytics
An institutional investor recently bought a new position in Cardlytics stock. Worldly Partners Management LLC purchased a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 115,798 shares of the company's stock, valued at approximately $520,000. Cardlytics accounts for approximately 0.4% of Worldly Partners Management LLC's investment portfolio, making the stock its 3rd biggest position. Worldly Partners Management LLC owned about 1.99% of Cardlytics at the end of the most recent quarter. 68.10% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on CDLX shares. Weiss Ratings reiterated a "sell (e+)" rating on shares of Cardlytics in a research note on Wednesday, July 8th. Needham & Company LLC reissued a "hold" rating on shares of Cardlytics in a report on Thursday, June 18th. Finally, Wall Street Zen downgraded Cardlytics from a "hold" rating to a "sell" rating in a research note on Saturday, September 19th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Sell" and a consensus price target of $10.00.
Get Our Latest Report on CDLX
Cardlytics Company Profile
(
Get Free Report)
Cardlytics, Inc is an advertising technology company that connects marketers with consumers through financial institutions. Its platform uses transaction-based insights to help advertisers reach customers with relevant offers and measure the impact of advertising on consumer spending.
Cardlytics' services are integrated into banking and financial applications, where consumers may receive personalized cash-back offers, discounts and other promotions based on their shopping activity. Participating financial institutions can use the platform to provide additional value to customers while generating advertising revenue.
The company serves advertisers across categories such as retail, dining, travel and financial services, and works with banks and other financial institutions primarily in the United States and the United Kingdom.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
